X9S
3-tert-butyl-N-[(1R)-6-{2-[5-methyl-1-(oxan-4-yl)-1H-pyrazol-4-yl]-3H-imidazo[4,5-b]pyridin-7-yl}-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-5-carboxamide
| Created: | 2020-12-07 |
| Last modified: | 2021-05-19 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 79 |
| Chiral Atom Count | 1 |
| Bond Count | 85 |
| Aromatic Bond Count | 26 |
Chemical Component Summary | |
|---|---|
| Name | 3-tert-butyl-N-[(1R)-6-{2-[5-methyl-1-(oxan-4-yl)-1H-pyrazol-4-yl]-3H-imidazo[4,5-b]pyridin-7-yl}-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-5-carboxamide |
| Systematic Name (OpenEye OEToolkits) | 3-~{tert}-butyl-~{N}-[(1~{R})-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-3~{H}-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-5-carboxamide |
| Formula | C32 H36 N8 O3 |
| Molecular Weight | 580.68 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 12.01 | c1(ccc2c(c1)CCCC2NC(c3nc(no3)C(C)(C)C)=O)c4ccnc5c4nc(n5)c7c(C)n(C6CCOCC6)nc7 |
| SMILES | CACTVS | 3.385 | Cc1n(ncc1c2[nH]c3nccc(c4ccc5[CH](CCCc5c4)NC(=O)c6onc(n6)C(C)(C)C)c3n2)C7CCOCC7 |
| SMILES | OpenEye OEToolkits | 2.0.7 | Cc1c(cnn1C2CCOCC2)c3[nH]c4c(n3)c(ccn4)c5ccc6c(c5)CCCC6NC(=O)c7nc(no7)C(C)(C)C |
| Canonical SMILES | CACTVS | 3.385 | Cc1n(ncc1c2[nH]c3nccc(c4ccc5[C@@H](CCCc5c4)NC(=O)c6onc(n6)C(C)(C)C)c3n2)C7CCOCC7 |
| Canonical SMILES | OpenEye OEToolkits | 2.0.7 | Cc1c(cnn1C2CCOCC2)c3[nH]c4c(n3)c(ccn4)c5ccc6c(c5)CCC[C@H]6NC(=O)c7nc(no7)C(C)(C)C |
| InChI | InChI | 1.03 | InChI=1S/C32H36N8O3/c1-18-24(17-34-40(18)21-11-14-42-15-12-21)27-36-26-23(10-13-33-28(26)37-27)20-8-9-22-19(16-20)6-5-7-25(22)35-29(41)30-38-31(39-43-30)32(2,3)4/h8-10,13,16-17,21,25H,5-7,11-12,14-15H2,1-4H3,(H,35,41)(H,33,36,37)/t25-/m1/s1 |
| InChIKey | InChI | 1.03 | IWJJKWNPIYKQNB-RUZDIDTESA-N |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 146437414 |














